The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, C.-R.
Right arrow Articles by Lin, W.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C.-R.
Right arrow Articles by Lin, W.-W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2005, 174: 1647-1656.
Copyright © 2005 by The American Association of Immunologists

Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-{kappa}B-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression1

Chia-Ron Yang*, Shie-Liang Hsieh{dagger},{ddagger}, Feng-Ming Ho§ and Wan-Wan Lin2,*

* Department of Pharmacology, College of Medicine, National Taiwan University, {dagger} Department of Microbiology and Immunology, and Immunology Research Center, National Yang-Ming University, Taipei, Taiwan, and {ddagger} Genomics Research Center, Academia Sinica, Taipei, Taiwan; and § Department of Internal Medicine, Tao-Yuan General Hospital Department of Health, Taoyuan, Taiwan

Decoy receptor 3 (DcR3), a soluble receptor for FasL, LIGHT and TL1A, is highly expressed in cancer cells. We show that pretreatment of HUVECs with DcR3 enhances the adhesion of THP-1 and U937 cells and primary monocytes. A similar stimulatory effect of DcR3 on THP-1 adhesion was also observed in human microvascular endothelial cells (HMVECs). Flow cytometry and ELISA showed that DcR3-treated HUVECs exhibited significant increases in ICAM-1 and VCAM-1 expression. We also demonstrate the ability of DcR3 to stimulate the secretion of IL-8 by HUVECs. RT-PCR and reporter assays revealed that the expression of adhesion molecules and IL-8 are regulated at the level of gene transcription. Experiments with pyrrolidine dithiocarbamate indicated the involvement of an NF-{kappa}B signaling pathway. DcR3 was found to induce I{kappa}B kinase activation, I{kappa}B degradation, p65 nuclear translocation, and NF-{kappa}B DNA-binding activity. The enhancement by DcR3 of cell adhesion to HUVECs was not mimicked by the TL1A-Ab, which has been shown in our previous work to be a neutralizing Ab against TL1A, thereby inducing HUVECs angiogenesis. Moreover, DcR3-induced cell adhesion could be detected in human aortic endothelial cells (ECs) in which TL1A expression is lacking. Together, our data demonstrate that DcR3 increases monocyte adhesion to ECs via NF-{kappa}B activation, leading to the transcriptional up-regulation of adhesion molecules and IL-8 in ECs. This novel action appears not to be due to TL1A neutralization, but occurs through an as yet undefined target(s). This study implicates DcR3 in the relationship between inflammation and cancer development.




This article has been cited by other articles:


Home page
GutHome page
B Funke, F Autschbach, S Kim, F Lasitschka, U Strauch, G Rogler, G Gdynia, L Li, N Gretz, S Macher-Goeppinger, et al.
Functional characterisation of decoy receptor 3 in Crohn's disease
Gut, April 1, 2009; 58(4): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P.-H. Chen and C.-R. Yang
Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-{kappa}B-Dependent Pathway
J. Immunol., December 15, 2008; 181(12): 8441 - 8449.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Kavurma, N. Y. Tan, and M. R. Bennett
Death Receptors and Their Ligands in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1694 - 1702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-H. Ho, C.-F. Hsu, P.-F. Fong, S.-K. Tai, S.-L. Hsieh, and C.-J. Chen
Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter
J. Virol., May 1, 2007; 81(9): 4837 - 4847.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H. Lu, W. Ouyang, and C. Huang
Inflammation, a Key Event in Cancer Development
Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Amin, C. S. Haas, K. Zhu, P. J. Mansfield, M. J. Kim, N. P. Lackowski, and A. E. Koch
Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF{kappa}B
Blood, March 15, 2006; 107(6): 2252 - 2261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-C. Chang, Y.-H. Chan, D. G. Jackson, and S.-L. Hsieh
The Glycosaminoglycan-Binding Domain of Decoy Receptor 3 Is Essential for Induction of Monocyte Adhesion
J. Immunol., January 1, 2006; 176(1): 173 - 180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.